deltatrials

Extragonadal germ cell tumor Trials in New York, United States

Conditions / Extragonadal germ cell tumor / New York, United States

Extragonadal germ cell tumor is a medical condition with active clinical research programs worldwide.

15 total trials for this combination

Showing top 10 of 15 trials

Trials

NCT ID Title Status Phase
NCT00470366 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors COMPLETED PHASE2
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors COMPLETED PHASE2
NCT00072215 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors TERMINATED PHASE3
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy COMPLETED PHASE3
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer COMPLETED
NCT00002596 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors COMPLETED PHASE3
NCT00003173 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors COMPLETED PHASE2
NCT00002515 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer COMPLETED PHASE2
NCT00003811 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors COMPLETED PHASE2
NCT00036842 Arsenic Trioxide in Treating Men With Germ Cell Cancer COMPLETED PHASE2

Related Pages